Chronic Nicotine Consumption Does Not Influence 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone–Induced Lung Tumorigenesis
- 1 November 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 4 (11) , 1752-1760
Abstract
Nicotine replacement therapy is often used to maintain smoking cessation. However, concerns exist about the safety of long-term nicotine replacement therapy use in ex-smokers and its concurrent use in smokers. In this study, we determined the effect of nicotine administration on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumors in A/J mice. Female mice were administered a single dose of NNK (10 μmol) and 0.44 μmol/mL nicotine in the drinking water. Nicotine was administered 2 weeks prior to NNK, 44 weeks after NNK, throughout the experiment, or without NNK treatment. The average weekly consumption of nicotine-containing water was 15 ± 3 mL per mouse, resulting in an estimated daily nicotine dose of 0.9 μmol (0.15 mg) per mouse. Nicotine administration alone for 46 weeks did not increase lung tumor multiplicity (0.32 ± 0.1 vs. 0.53 ± 0.1 tumors per mouse). Lung tumor multiplicity in NNK-treated mice was 18.4 ± 4.5 and was not different for mice consuming nicotine before or after NNK administration, 21.9 ± 5.3 and 20.0 ± 5.4 tumors per mouse, respectively. Lung tumor multiplicity in animals consuming nicotine both before and after NNK administration was 20.4 ± 5.4. Tumor size and progression of adenomas to carcinomas was also not affected by nicotine consumption. In addition, nicotine consumption had no effect on the level of O6-methylguanine in the lung of NNK-treated mice. These negative findings in a commonly used model of human lung carcinogenesis should lead us to question the interpretation of the many in vitro studies that find that nicotine stimulates cancer cell growth. Cancer Prev Res; 4(11); 1752–60. ©2011 AACR.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung CancerPLOS ONE, 2009
- Indole-3-carbinol Inhibits 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Plus Benzo(a)pyrene–Induced Lung Tumorigenesis in A/J Mice and Modulates Carcinogen-Induced Alterations in Protein LevelsCancer Research, 2007
- Classification of Proliferative Pulmonary Lesions of the MouseCancer Research, 2004
- Tobacco carcinogens, their biomarkers and tobacco-induced cancerNature Reviews Cancer, 2003
- Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3Carcinogenesis, 2003
- Effect of nicotine, cotinine and phenethyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in the Syrian golden hamsterToxicology, 2002
- Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosisNature Medicine, 2001
- The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 2001
- Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lungLung Cancer, 2001
- N-Nitrosobenzylmethylamine Hydroxylation and Coumarin 7-Hydroxylation: Catalysis by Rat Esophageal Microsomes and Cytochrome P450 2A3 and 2A6 EnzymesChemical Research in Toxicology, 1999